SCHEMBL2226261

SCHEMBL2226261

CS(=O)(=O)c1ccc(S(N)(=O)=O)cc1CNc1cc(Nc2ccc(Cl)cn2)ncn1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 9/20 0.58
BRAF P15056 6/20 0.58
EGFR P00533 2/20 0.46
MAPK10 P53779 1/20 0.40
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
IDH1 O75874 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ERBB3 P21860 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226032 0.90 BRAF (0.60) TNNI3KBRAFEGFRMAPK10CDK1
SCHEMBL2227374 0.88 CDK1 (0.51) TNNI3KBRAFEGFRCDK1CCNB1
SCHEMBL2226017 0.87 BRAF (0.43) TNNI3KBRAFEGFRCDK1CCNB1
SCHEMBL2225873 0.85 TNNI3K (0.46) TNNI3KBRAFEGFRMAPK10CDK1
SCHEMBL2225756 0.85 BRAF (0.62) TNNI3KBRAFEGFRCA1CA2
SCHEMBL2227169 0.83 CDK1 (0.40) TNNI3KBRAFEGFRCDK1CCNB1
SCHEMBL2227178 0.81 TNNI3K (0.61) TNNI3KBRAFEGFRMAPK10CDK1
Trifluoroacetic Acid SCHEMBL2225019 0.81 TNNI3K (0.44) TNNI3KEGFRCDK1CCNB1CCNA2
SCHEMBL2225876 0.81 BRAF (0.63) TNNI3KBRAFEGFRMAPK10CDK1
SCHEMBL2225414 0.80 CDK1 (0.46) TNNI3KBRAFEGFRCDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed